Meeting
Abstract Number: 83
Hospital Medicine 2020, Virtual Competition
Background: The US has a heavy burden of deaths from opioid overdoses, and New Mexico is not excepted from this. Treatment options for opioid use disorder (OUD) are buprenorphine/naloxone (“Suboxone”), methadone, naltrexone, counseling, and/or behavioral therapy. Long-acting oral opioids like Suboxone, are the most effective methods for treating opioid withdrawal and OUD. They are often […]
Abstract Number: 138
Hospital Medicine 2020, Virtual Competition
Background: Persons with opioid use disorders (OUD) represent a disproportionately high percentage of hospitalized patients, have greater lengths of stay and readmissions, can incur higher costs, and are at greater risk of drug-related death immediately post-discharge. Further, despite the availability of effective medications for OUD, patients often are not offered treatment during the inpatient encounter. […]
Abstract Number: 255
Hospital Medicine 2020, Virtual Competition
Background: Inpatient addiction consultant services are an innovative and proliferating tool used to confront the opioid epidemic. As healthcare systems seek to address gaps in care for patients with substance use disorder (SUD), the inpatient setting is increasingly understood as a unique opportunity for counseling, referral for treatment, and initiation of medication assistance treatment (MAT) […]
Abstract Number: 412
Hospital Medicine 2020, Virtual Competition
Background: Opioid use disorder (OUD) is a highly prevalent medical condition that is associated with significant morbidity and mortality. As rates of opioid addiction have increased in the last several years, hospitalists are uniquely positioned at the front lines to initiate evidence-based treatment for patients who are admitted with comorbid OUD and help link patients […]